BUMEX Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Bumex, and when can generic versions of Bumex launch?

Bumex is a drug marketed by Validus Pharms and is included in two NDAs.

The generic ingredient in BUMEX is bumetanide. There are six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the bumetanide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Bumex

A generic version of BUMEX was approved as bumetanide by HOSPIRA on October 31^st, 1994.

Try a Trial

Summary for BUMEX

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	4
Raw Ingredient (Bulk) Api Vendors:	116
Patent Applications:	5,122
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in BUMEX?	BUMEX excipients list
DailyMed Link:	BUMEX at DailyMed

Drug patent expirations by year for BUMEX

Pharmacology for BUMEX

Drug Class	Loop Diuretic
Physiological Effect	Increased Diuresis at Loop of Henle

Anatomical Therapeutic Chemical (ATC) Classes for BUMEX

C03CA	Sulfonamides, plain
C03C	HIGH-CEILING DIURETICS
C03	DIURETICS
C	Cardiovascular system

US Patents and Regulatory Information for BUMEX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Validus Pharms	BUMEX	bumetanide	INJECTABLE;INJECTION	018226-001	Feb 28, 1983		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	AB	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-002	Feb 28, 1983	AB	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-001	Feb 28, 1983	AB	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for BUMEX

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-002	Feb 28, 1983	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-002	Feb 28, 1983	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	BUMEX	bumetanide	INJECTABLE;INJECTION	018226-001	Feb 28, 1983	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	BUMEX	bumetanide	TABLET;ORAL	018225-003	Jun 14, 1985	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for BUMEX

See the table below for patents covering BUMEX around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
France	2027043		⤷ Try a Trial
Japan	S4913899		⤷ Try a Trial
Denmark	134548		⤷ Try a Trial
Sweden	380013		⤷ Try a Trial
Switzerland	532559	Verfahren zur Herstellung von Sulfamylbenzoesäure-Derivaten und deren Verwendung	⤷ Try a Trial
Netherlands	154727		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for BUMEX

Pharmacology for BUMEX

Anatomical Therapeutic Chemical (ATC) Classes for BUMEX

Make Better Decisions: Try a trial or see plans & pricing